Yashvant Gopinath Khaire
About Yashvant Gopinath Khaire
Data last updated:
Yashvant Gopinath Khaire is a Director at Indiwell Pharmaceuticals Private Limited (since 2017). The company operates in Trading. Indiwell Pharmaceuticals Private Limited reported revenue of ₹8.3 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Indiwell Pharmaceuticals Private Limited U51909MH2017PTC295665 | Director | 01 Jun 2017 | 2017 | ₹8.3 Lakh (FY 2022) | Active |
Board colleagues of Yashvant Gopinath Khaire
| Name | DIN | Company | Designation |
|---|---|---|---|
| Shankar Tukaram Sonawane | 07826651 | Indiwell Pharmaceuticals Private Limited | Director |
| Yogesh Balu Sonawane | 07826666 | Indiwell Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yashvant Gopinath Khaire
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yashvant Gopinath Khaire
Yashvant Gopinath Khaire currently holds 1 directorship: Indiwell Pharmaceuticals Private Limited (Director, since 01 Jun 2017, revenue ₹8.3 Lakh (FY 2022)).
Yashvant Gopinath Khaire was first appointed on 01 Jun 2017 as Director at Indiwell Pharmaceuticals Private Limited.
The current boards of Yashvant Gopinath Khaire's companies include Shankar Tukaram Sonawane (Indiwell Pharmaceuticals Private Limited), Yogesh Balu Sonawane (Indiwell Pharmaceuticals Private Limited).